119 related articles for article (PubMed ID: 28754419)
1. Evaluation of tolerance to lentiviral LV-RPE65 gene therapy vector after subretinal delivery in non-human primates.
Matet A; Kostic C; Bemelmans AP; Moulin A; Rosolen SG; Martin S; Mavilio F; Amirjanians V; Stieger K; Lorenz B; Behar-Cohen F; Arsenijevic Y
Transl Res; 2017 Oct; 188():40-57.e4. PubMed ID: 28754419
[TBL] [Abstract][Full Text] [Related]
2. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis.
Jacobson SG; Boye SL; Aleman TS; Conlon TJ; Zeiss CJ; Roman AJ; Cideciyan AV; Schwartz SB; Komaromy AM; Doobrajh M; Cheung AY; Sumaroka A; Pearce-Kelling SE; Aguirre GD; Kaushal S; Maguire AM; Flotte TR; Hauswirth WW
Hum Gene Ther; 2006 Aug; 17(8):845-58. PubMed ID: 16942444
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis.
Bemelmans AP; Kostic C; Crippa SV; Hauswirth WW; Lem J; Munier FL; Seeliger MW; Wenzel A; Arsenijevic Y
PLoS Med; 2006 Oct; 3(10):e347. PubMed ID: 17032058
[TBL] [Abstract][Full Text] [Related]
4. Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection.
Jacobson SG; Acland GM; Aguirre GD; Aleman TS; Schwartz SB; Cideciyan AV; Zeiss CJ; Komaromy AM; Kaushal S; Roman AJ; Windsor EA; Sumaroka A; Pearce-Kelling SE; Conlon TJ; Chiodo VA; Boye SL; Flotte TR; Maguire AM; Bennett J; Hauswirth WW
Mol Ther; 2006 Jun; 13(6):1074-84. PubMed ID: 16644289
[TBL] [Abstract][Full Text] [Related]
5. Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
Rolling F; Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
Bull Mem Acad R Med Belg; 2006; 161(10-12):497-508; discussion 508-9. PubMed ID: 17503728
[TBL] [Abstract][Full Text] [Related]
6. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.
Acland GM; Aguirre GD; Bennett J; Aleman TS; Cideciyan AV; Bennicelli J; Dejneka NS; Pearce-Kelling SE; Maguire AM; Palczewski K; Hauswirth WW; Jacobson SG
Mol Ther; 2005 Dec; 12(6):1072-82. PubMed ID: 16226919
[TBL] [Abstract][Full Text] [Related]
7. Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
Gene Ther; 2007 Feb; 14(4):292-303. PubMed ID: 17024105
[TBL] [Abstract][Full Text] [Related]
8. Acute toxicity study of a simian immunodeficiency virus-based lentiviral vector for retinal gene transfer in nonhuman primates.
Ikeda Y; Yonemitsu Y; Miyazaki M; Kohno R; Murakami Y; Murata T; Goto Y; Tabata T; Ueda Y; Ono F; Suzuki T; Ageyama N; Terao K; Hasegawa M; Sueishi K; Ishibashi T
Hum Gene Ther; 2009 Sep; 20(9):943-54. PubMed ID: 19416079
[TBL] [Abstract][Full Text] [Related]
9. Vesicular stomatitis virus glycoprotein- and Venezuelan equine encephalitis virus-derived glycoprotein-pseudotyped lentivirus vectors differentially transduce corneal endothelium, trabecular meshwork, and human photoreceptors.
Lipinski DM; Barnard AR; Charbel Issa P; Singh MS; De Silva SR; Trabalza A; Eleftheriadou I; Ellison SM; Mazarakis ND; MacLaren RE
Hum Gene Ther; 2014 Jan; 25(1):50-62. PubMed ID: 24125177
[TBL] [Abstract][Full Text] [Related]
10. Stable retinal gene expression in nonhuman primates via subretinal injection of SIVagm-based lentiviral vectors.
Ikeda Y; Yonemitsu Y; Miyazaki M; Kohno R; Murakami Y; Murata T; Tabata T; Ueda Y; Ono F; Suzuki T; Ageyama N; Terao K; Hasegawa M; Sueishi K; Ishibashi T
Hum Gene Ther; 2009 Jun; 20(6):573-9. PubMed ID: 19257835
[TBL] [Abstract][Full Text] [Related]
11. Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin.
Ye GJ; Budzynski E; Sonnentag P; Miller PE; Sharma AK; Ver Hoeve JN; Howard K; Knop DR; Neuringer M; McGill T; Stoddard J; Chulay JD
Hum Gene Ther Clin Dev; 2015 Sep; 26(3):165-76. PubMed ID: 26390090
[TBL] [Abstract][Full Text] [Related]
12. Electroretinographic analyses of Rpe65-mutant rd12 mice: developing an in vivo bioassay for human gene therapy trials of Leber congenital amaurosis.
Roman AJ; Boye SL; Aleman TS; Pang JJ; McDowell JH; Boye SE; Cideciyan AV; Jacobson SG; Hauswirth WW
Mol Vis; 2007 Sep; 13():1701-10. PubMed ID: 17960108
[TBL] [Abstract][Full Text] [Related]
13. Outer Plexiform Layer Structures Are Not Altered Following AAV-Mediated Gene Transfer in Healthy Rat Retina.
Giers BC; Klein D; Mendes-Madeira A; Isiegas C; Lorenz B; Haverkamp S; Stieger K
Front Neurol; 2017; 8():59. PubMed ID: 28280483
[TBL] [Abstract][Full Text] [Related]
14. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.
Bennett J; Wellman J; Marshall KA; McCague S; Ashtari M; DiStefano-Pappas J; Elci OU; Chung DC; Sun J; Wright JF; Cross DR; Aravand P; Cyckowski LL; Bennicelli JL; Mingozzi F; Auricchio A; Pierce EA; Ruggiero J; Leroy BP; Simonelli F; High KA; Maguire AM
Lancet; 2016 Aug; 388(10045):661-72. PubMed ID: 27375040
[TBL] [Abstract][Full Text] [Related]
15. Postsurgical assessment and long-term safety of recombinant adeno-associated virus-mediated gene transfer into the retinas of dogs and primates.
Le Meur G; Weber M; Péréon Y; Mendes-Madeira A; Nivard D; Deschamps JY; Moullier P; Rolling F
Arch Ophthalmol; 2005 Apr; 123(4):500-6. PubMed ID: 15824224
[TBL] [Abstract][Full Text] [Related]
16. Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency.
Pang J; Boye SE; Lei B; Boye SL; Everhart D; Ryals R; Umino Y; Rohrer B; Alexander J; Li J; Dai X; Li Q; Chang B; Barlow R; Hauswirth WW
Gene Ther; 2010 Jul; 17(7):815-26. PubMed ID: 20237510
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer to the nonhuman primate retina with recombinant feline immunodeficiency virus vectors.
Lotery AJ; Derksen TA; Russell SR; Mullins RF; Sauter S; Affatigato LM; Stone EM; Davidson BL
Hum Gene Ther; 2002 Apr; 13(6):689-96. PubMed ID: 11936968
[TBL] [Abstract][Full Text] [Related]
18. Improving the Transduction of Bone Marrow-Derived Cells with an Integrase-Defective Lentiviral Vector.
Pay SL; Qi X; Willard JF; Godoy J; Sankhavaram K; Horton R; Mitter SK; Quigley JL; Chang LJ; Grant MB; Boulton ME
Hum Gene Ther Methods; 2018 Feb; 29(1):44-59. PubMed ID: 29160102
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy in the second eye of RPE65-deficient dogs improves retinal function.
Annear MJ; Bartoe JT; Barker SE; Smith AJ; Curran PG; Bainbridge JW; Ali RR; Petersen-Jones SM
Gene Ther; 2011 Jan; 18(1):53-61. PubMed ID: 20703309
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy Evaluation of rAAV2tYF-PR1.7-hCNGA3 Vector Delivered by Subretinal Injection in CNGA3 Mutant Achromatopsia Sheep.
Gootwine E; Ofri R; Banin E; Obolensky A; Averbukh E; Ezra-Elia R; Ross M; Honig H; Rosov A; Yamin E; Ye GJ; Knop DR; Robinson PM; Chulay JD; Shearman MS
Hum Gene Ther Clin Dev; 2017 Jun; 28(2):96-107. PubMed ID: 28478700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
